SLG
ALXN

Stanley-Laman Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Stanley-Laman Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,562
Closed -$870K – 364
2015
Q4 		$870K Buy
+4,562
New +$870K 0.15% 159